News

AstraZeneca (LSE:AZN) Gains EU Approval For Breast Cancer Treatment DATROWAY
AstraZeneca (LSE:AZN) saw its share price decline by 3.5% in the last quarter, a period marked by several key developments, including the European approval of DATROWAY for breast cancer treatment and ...
PMLive2d
AstraZeneca/Daiichi Sankyo’s Datroway approved by EC to treat breast cancer
AstraZeneca (AZ) and Daiichi Sankyo’s Datroway (datopotamab deruxtecan) has been approved by the European Commission (EC) for ...
DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...
pharmaphorum4d
AZ, Daiichi get EU okay for breast cancer drug Datroway
AstraZeneca and Daiichi Sankyo have claimed approval from the European Commission for their TROP2-directed antibody-drug ...
The Pharma Letter4d
First approval in the EU for Daiichi Sankyo and AstraZeneca’s Datroway
Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...
Seeking Alpha4d
DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
First approval in the EU for Daiichi Sankyo and AstraZeneca’s DATROWAY based on TROPION-Breast01 trial showing 37% reduction in the risk of disease progression or death versus chemotherapy ...
Fierce Biotech3d
From ADCs to radiopharma: How AstraZeneca is trying to 'redefine oncology care'
AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...
Daiichi Sankyo and AstraZeneca secure EU approval for Datroway
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company, and ...